We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$565M
AUM Growth
+$42.1M
Cap. Flow
-$2.06M
Cap. Flow %
-0.36%
Top 10 Hldgs %
37.22%
Holding
341
New
23
Increased
52
Reduced
104
Closed
29

Top Buys

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$2.8M
2
APD icon
Air Products & Chemicals
APD
+$2.39M
3
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.22M
4
WSO icon
Watsco Inc
WSO
+$1.62M
5
P
Everpure Inc
P
+$1.61M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.56M
2
PEP icon
PepsiCo
PEP
+$1.42M
3
TT icon
Trane Technologies
TT
+$1.18M
4
AVGO icon
Broadcom
AVGO
+$1.17M
5
TSCO icon
Tractor Supply
TSCO
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 36.21%
2 Healthcare 13.53%
3 Consumer Discretionary 10.22%
4 Industrials 8.96%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
76
S&P Global
SPGI
$121B
$715K 0.13%
1,680
– –
XOM icon
77
ExxonMobil
XOM
$657B
$708K 0.13%
6,092
+5
+0.1% +$523
SHOP icon
78
Shopify
SHOP
$200B
$688K 0.12%
8,910
– –
FTV icon
79
Fortive
FTV
$18.6B
$688K 0.12%
10,607
-378
-3% -$22.9K
EEMA icon
80
iShares MSCI Emerging Markets Asia ETF
EEMA
$857M
$607K 0.11%
8,919
-75
-0.8% -$4.91K
SRCL
81
DELISTED
Stericycle Inc
SRCL
$528K 0.09%
10,000
– –
IBDP
82
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$508K 0.09%
20,275
– –
RBA icon
83
RB Global
RBA
$17.4B
$507K 0.09%
6,650
+825
+14% +$57.6K
NFLX icon
84
Netflix
NFLX
$318B
$500K 0.09%
8,240
-90
-1% -$5.07K
FCX icon
85
Freeport-McMoran
FCX
$98.7B
$470K 0.08%
10,000
– –
BMY icon
86
Bristol-Myers Squibb
BMY
$132B
$460K 0.08%
8,491
-30,637
-78% -$1.56M
BKNG icon
87
Booking.com
BKNG
$160B
$457K 0.08%
3,150
– –
HUBS icon
88
HubSpot
HUBS
$10.8B
$439K 0.08%
700
– –
NVO
89
Novo Nordisk
NVO
$209B
$431K 0.08%
3,354
– –
JPM icon
90
JPMorgan Chase
JPM
$956B
$408K 0.07%
2,038
+16
+0.8% +$2.89K
CRM icon
91
Salesforce
CRM
$162B
$400K 0.07%
1,328
+221
+20% +$63.8K
EXPD icon
92
Expeditors International
EXPD
$23.3B
$395K 0.07%
3,250
-400
-11% -$49.4K
CTAS icon
93
Cintas
CTAS
$81.1B
$388K 0.07%
2,260
– –
PG icon
94
Procter & Gamble
PG
$340B
$378K 0.07%
2,331
-4,572
-66% -$717K
VMI icon
95
Valmont Industries
VMI
$9.5B
$358K 0.06%
1,568
-95
-6% -$21.3K
KNSL icon
96
Kinsale Capital Group
KNSL
$8.4B
$357K 0.06%
680
-42
-6% -$19K
IBDQ
97
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$341K 0.06%
13,750
– –
BR icon
98
Broadridge
BR
$19.8B
$328K 0.06%
1,600
– –
EPD icon
99
Enterprise Products Partners
EPD
$82B
$325K 0.06%
11,141
– –
VRSK icon
100
Verisk Analytics
VRSK
$23.6B
$321K 0.06%
1,360
– –
2 3
4
5 6

Similar funds

CGIM
Capital Group Investment Management Raffles Quay, Singapore $585M AUM 31.36% 1-Year Est. Return
TAM
Talos Asset Management New York $585M AUM 204.8% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $586M AUM 15.35% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return
DLCIG
D.L. Carlson Investment Group Concord, New Hampshire $582M AUM 29.47% 1-Year Est. Return
TCM
Trybe Capital Management Greenwich, Connecticut $581M AUM 112.96% 1-Year Est. Return
FMI
Frec Markets Inc San Francisco, California $587M AUM
PFG
Premier Financial Group Eureka, California $587M AUM 21.88% 1-Year Est. Return

Arcadia Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Arcadia Investment Management held 341 positions worth $565M, up 8% from $523M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arcadia Investment Management's Q1 2024 filing shows 23 new, 52 increased, 104 reduced and 29 closed positions. Its largest new stake was Dyne Therapeutics: 31,325 shares worth $889K. The largest sale was Bristol-Myers Squibb, an estimated $1.56M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q1 2024 buy was Dyne Therapeutics: 31,325 shares worth $889K.
  • Arcadia Investment Management added most to Mobileye in Q1 2024, an estimated $2.8M increase.
  • Arcadia Investment Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $1.56M.
  • Arcadia Investment Management fully exited East-West Bancorp in Q1 2024, selling an estimated $737K.
  • Arcadia Investment Management's ten largest holdings make up 37% of its $565M portfolio in Q1 2024.
  • Arcadia Investment Management opened 23 new positions and closed 29 in Q1 2024.
  • Arcadia Investment Management's portfolio value rose 8% quarter-over-quarter to $565M.

Based on Arcadia Investment Management's 13F filing for Q1 2024, filed 23 Apr 2024.